Variant report

Variant	esv3373822
Chromosome Location	chr11:64182426-64184924
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:48)
CpG islands
(count:61)
Chromatin interactive
region (count:15)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:48 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr11:64182578-64182683	H1-hESC	embryonic stem cell:	n/a	n/a
2	CTCF	chr11:64183611-64183656	MCF-7	breast:	n/a	n/a
3	EGR1	chr11:64182801-64183064	K562	blood:	n/a	n/a
4	EGR1	chr11:64182809-64183077	K562	blood:	n/a	n/a
5	ELF1	chr11:64183580-64183942	GM12878	blood:	n/a	n/a
6	EP300	chr11:64183407-64183887	GM12878	blood:	n/a	n/a
7	ESR1	chr11:64182451-64182783	ECC-1	luminal epithelium:	n/a	chr11:64182651-64182666
8	ESR1	chr11:64182523-64182839	ECC-1	luminal epithelium:	n/a	chr11:64182651-64182666
9	ESR1	chr11:64182556-64182744	ECC-1	luminal epithelium:	n/a	chr11:64182651-64182666
10	ESR1	chr11:64182509-64182735	T-47D	breast:	n/a	chr11:64182651-64182666
11	JUN	chr11:64183930-64184130	HepG2	liver:	n/a	chr11:64184002-64184015 chr11:64184003-64184012
12	JUND	chr11:64183870-64184028	H1-hESC	embryonic stem cell:	n/a	chr11:64183971-64183982 chr11:64184003-64184012
13	JUND	chr11:64183856-64184164	HepG2	liver:	n/a	chr11:64183971-64183982 chr11:64184003-64184012
14	MAX	chr11:64183321-64183950	K562	blood:	n/a	chr11:64183795-64183805
15	MAX	chr11:64183799-64183861	HepG2	liver:	n/a	n/a
16	MAX	chr11:64183509-64183907	NB4	blood:	n/a	chr11:64183795-64183805
17	MAX	chr11:64183296-64183496	H1-hESC	embryonic stem cell:	n/a	n/a
18	MAX	chr11:64183743-64183914	A549	lung:	n/a	chr11:64183795-64183805
19	MYC	chr11:64183598-64183649	MCF-7	breast:	n/a	n/a
20	MYC	chr11:64183731-64183740	MCF-7	breast:	n/a	n/a
21	MYC	chr11:64183526-64183799	GM12878	blood:	n/a	n/a
22	MYC	chr11:64183403-64183528	MCF-7	breast:	n/a	n/a
23	MYC	chr11:64183529-64183730	MCF-7	breast:	n/a	n/a
24	MYC	chr11:64183540-64183661	MCF-7	breast:	n/a	n/a
25	MYC	chr11:64183741-64183754	MCF-7	breast:	n/a	n/a
26	MYC	chr11:64183656-64183730	MCF-7	breast:	n/a	n/a
27	MYC	chr11:64183418-64183826	MCF-7	breast:	n/a	chr11:64183795-64183805
28	MYC	chr11:64183583-64183593	MCF-7	breast:	n/a	n/a
29	MYC	chr11:64183481-64183493	MCF-7	breast:	n/a	n/a
30	MYC	chr11:64183543-64183549	MCF-7	breast:	n/a	n/a
31	PAX5	chr11:64183198-64184055	GM12878	blood:	n/a	n/a
32	PAX5	chr11:64183411-64183807	GM12878	blood:	n/a	n/a
33	POLR2A	chr11:64183566-64183768	A549	lung:	n/a	n/a
34	POLR2A	chr11:64183608-64183835	MCF-7	breast:	n/a	n/a
35	POLR2A	chr11:64183528-64184016	HL-60	blood:	n/a	n/a
36	POLR2A	chr11:64183268-64184070	GM12892	blood:	n/a	n/a
37	POLR2A	chr11:64183487-64183813	Gliobla	brain:	n/a	n/a
38	POLR2A	chr11:64183305-64183970	GM12878	blood:	n/a	n/a
39	POLR2A	chr11:64183771-64183811	A549	lung:	n/a	n/a
40	POLR2A	chr11:64183434-64183907	MCF-7	breast:	n/a	n/a
41	POLR2A	chr11:64183457-64183470	Gliobla	brain:	n/a	n/a
42	REST	chr11:64183455-64183891	PANC-1	pancreas:	n/a	n/a
43	REST	chr11:64183751-64184006	PANC-1	pancreas:	n/a	chr11:64183913-64183922 chr11:64183894-64183903
44	RUNX3	chr11:64183403-64183875	GM12878	blood:	n/a	n/a
45	SP1	chr11:64183471-64183873	GM12878	blood:	n/a	n/a
46	TCF12	chr11:64183413-64183901	GM12878	blood:	n/a	n/a
47	TCF12	chr11:64183411-64183914	GM12878	blood:	n/a	n/a
48	TCF3	chr11:64183352-64183856	GM12878	blood:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:64183154-64183204	ovcar-3	ovarian:	n/a
2	chr11:64183154-64183204	AG04449	skin:	fetal
3	chr11:64183154-64183204	HRPEpiC	eye:	n/a
4	chr11:64183154-64183204	HUVEC	blood vessel:	n/a
5	chr11:64183154-64183204	MCF-7	breast:	n/a
6	chr11:64183154-64183204	HCT-116	colon:	n/a
7	chr11:64183154-64183204	HL-60	blood:	n/a
8	chr11:64183154-64183204	GM12892	blood:	n/a
9	chr11:64183154-64183204	NB4	blood:	n/a
10	chr11:64183154-64183204	U87	brain:	n/a
11	chr11:64183154-64183204	GM12878	blood:	n/a
12	chr11:64183154-64183204	HMEC	breast:	n/a
13	chr11:64183154-64183204	GM12891	blood:	n/a
14	chr11:64183154-64183204	K562	blood:	n/a
15	chr11:64183154-64183204	HEEpiC	esophagus:	n/a
16	chr11:64183154-64183204	SK-N-SH	brain:	n/a
17	chr11:64183154-64183204	GM19239	blood:	n/a
18	chr11:64183154-64183204	AoSMC	blood vessel:	n/a
19	chr11:64183154-64183204	Hela-S3	cervix:	n/a
20	chr11:64183154-64183204	NH-A	brain:	n/a
21	chr11:64183154-64183204	HRCEpiC	kidney:	n/a
22	chr11:64183154-64183204	AG04450	lung:	fetal
23	chr11:64183154-64183204	SK-N-SH_RA	brain:	n/a
24	chr11:64183154-64183204	RPTEC	kidney:	n/a
25	chr11:64183154-64183204	NT2-D1	testis:	n/a
26	chr11:64183154-64183204	MCF10A-Er-Src	breast:	n/a
27	chr11:64183154-64183204	PANC-1	pancreas:	n/a
28	chr11:64183154-64183204	AG10803	skin:	n/a
29	chr11:64183154-64183204	HNPCEpiC	eye:	n/a
30	chr11:64183154-64183204	AG09309	skin:	n/a
31	chr11:64183154-64183204	Hepatocyte	liver:	n/a
32	chr11:64183154-64183204	BJ	skin:	n/a
33	chr11:64183154-64183204	BE2_C	brain:	n/a
34	chr11:64183154-64183204	H1-hESC	embryonic stem cell:	embryo
35	chr11:64183154-64183204	PrEC	prostate:	n/a
36	chr11:64183154-64183204	HIPEpiC	eye:	n/a
37	chr11:64183154-64183204	T-47D	breast:	n/a
38	chr11:64183154-64183204	IMR90	lung:	fetal
39	chr11:64183154-64183204	Caco-2	colon:	n/a
40	chr11:64183154-64183204	HCM	heart:	n/a
41	chr11:64183154-64183204	GM06990	blood:	n/a
42	chr11:64183154-64183204	CMK	blood:	n/a
43	chr11:64183154-64183204	NHBE	bronchial:	n/a
44	chr11:64183154-64183204	A549	lung:	n/a
45	chr11:64183154-64183204	PFSK-1	brain:	n/a
46	chr11:64183154-64183204	HEK293	kidney:	embryo
47	chr11:64183154-64183204	HPAEpiC	pulmonary alveolar:	n/a
48	chr11:64183154-64183204	SKMC	muscle:	n/a
49	chr11:64183154-64183204	ProgFib	skin:	n/a
50	chr11:64183154-64183204	ECC-1	luminal epithelium:	n/a

(count:15 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	11:64184313-64187414..11:64530985-64535815	GM12878	blood:
2	11:64184313-64187414..11:64517861-64519906	GM12878	blood:
3	11:64184313-64187414..11:64642645-64655002	K562	blood:
4	11:64184313-64187414..11:64523887-64530985	Hela-S3	cervix:
5	11:64184313-64187414..11:64322633-64349180	Hela-S3	cervix:
6	11:64184313-64187414..11:64519906-64523887	Hela-S3	cervix:
7	11:64184313-64187414..11:64356433-64395036	GM12878	blood:
8	11:64184313-64187414..11:64415880-64426617	GM12878	blood:
9	11:64184313-64187414..11:64538326-64543055	GM12878	blood:
10	11:64184313-64187414..11:64535815-64538326	K562	blood:
11	11:64184313-64187414..11:64501239-64517861	GM12878	blood:
12	11:64184313-64187414..11:64489786-64499245	GM12878	blood:
13	11:64184313-64187414..11:64426650-64437729	K562	blood:
14	11:64184313-64187414..11:64402707-64415880	GM12878	blood:
15	chr11:64126488..64127016-chr11:64182265..64183106,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000231492	TF binding region
ENSG00000231492	CpG island
ENSG00000197891	chromatin interactions
ENSG00000068831	chromatin interactions
ENSG00000168065	chromatin interactions
ENSG00000110076	chromatin interactions
ENSG00000110047	chromatin interactions
ENSG00000068976	chromatin interactions
ENSG00000168066	chromatin interactions
ENSG00000237410	chromatin interactions
ENSG00000162302	chromatin interactions
ENSG00000230835	chromatin interactions

Extended variants
information (count: 97 )
Associated
traits (count: 100 )

Variant overlapped rSNPs/rCNVs (count:97 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs139562229	chr11:64182449-64182450	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs72927950	chr11:64182466-64182467	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs372702368	chr11:64182467-64182468	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs555535001	chr11:64182468-64182469	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs1783518	chr11:64182491-64182492	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs577165246	chr11:64182539-64182540	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs75641226	chr11:64182624-64182625	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs114000423	chr11:64182657-64182658	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs182169887	chr11:64182730-64182731	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs560140837	chr11:64182786-64182787	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs186815181	chr11:64182794-64182795	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs7928453	chr11:64182811-64182812	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs76246172	chr11:64182817-64182818	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs562654893	chr11:64182847-64182848	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs543785959	chr11:64182859-64182860	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs551064555	chr11:64182883-64182884	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs570935956	chr11:64182978-64182979	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs533131253	chr11:64183060-64183061	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs59129940	chr11:64183116-64183117	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs546973133	chr11:64183135-64183136	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs78600944	chr11:64183155-64183156	Enhancers Weak transcription Bivalent Enhancer	CpG island	1 gene(s)	Overlapped CNVs	n/a
22	rs192406514	chr11:64183197-64183198	Enhancers Weak transcription Bivalent Enhancer	CpG island	1 gene(s)	Overlapped CNVs	n/a
23	rs555335263	chr11:64183416-64183417	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs572025531	chr11:64183424-64183425	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs555668160	chr11:64183438-64183439	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs77968661	chr11:64183447-64183448	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs75515125	chr11:64183461-64183462	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs77143619	chr11:64183476-64183477	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs78585521	chr11:64183499-64183500	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs74488252	chr11:64183500-64183501	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs77773639	chr11:64183507-64183508	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs11231788	chr11:64183510-64183511	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs7929292	chr11:64183534-64183535	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs7926270	chr11:64183541-64183542	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs7939171	chr11:64183548-64183549	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs569081890	chr11:64183559-64183560	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs61884052	chr11:64183610-64183611	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs61884053	chr11:64183617-64183618	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs67544429	chr11:64183619-64183620	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs538066195	chr11:64183644-64183645	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs59890219	chr11:64183647-64183648	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs10897498	chr11:64183653-64183654	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs557389518	chr11:64183663-64183664	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs10897499	chr11:64183687-64183688	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs10897500	chr11:64183693-64183694	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs7117535	chr11:64183735-64183736	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs10897501	chr11:64183770-64183771	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs10897502	chr11:64183779-64183780	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs183404970	chr11:64183825-64183826	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs56768513	chr11:64183832-64183833	Enhancers Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:100)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Wilms tumour	21544195	CNVD
Autism	22495311	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Glioblastoma multiforme	21138945	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Pituitary adenoma	18645599	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Prostate cancer	18632612	CNVD
Glioblastoma multiforme	21080181	CNVD
Smith-Lemli-Opitz syndrome	21572526	CNVD
Multiple myeloma	16461302	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Metanephric adenoma	20802469	CNVD
Chordoma	21602918	CNVD
Melanoma	18172304	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
ovarian endometriomas	16273235	CNVD
Breast cancer	21785460	CNVD
Breast cancer	16417655	CNVD
Myelofibrosis	22110671	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Prostate cancer	17217626	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Breast cancer	21045282	CNVD
Breast cancer	21806811	CNVD
Breast cancer	22002566	CNVD
Ductal carcinoma	18381933	CNVD
Retinoblastoma	22278416	CNVD
Breast cancer	20953835	CNVD
oto-dental syndrome	17656375	CNVD
Asthma	21956041	CNVD
Breast cancer	17603634	CNVD
Ovarian neoplasms	16753589	CNVD
Non-small cell lung cancer	20864512	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21509527	CNVD
Anaplastic thyroid cancer	18753363	CNVD
Prostate cancer	18779856	CNVD
Cancer	17160897	CNVD
Breast cancer	17001317	CNVD
Oral squamous cell carcinoma	16619035	CNVD
Intracranial aneurysm	16715129	CNVD
Colorectal cancer	16272173	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Colorectal cancer	16882699	CNVD
Berardinelli-seip congenital generalized lipodystrophy	17668395	CNVD
Spinal muscular atrophy	17668395	CNVD
Neonatal seizures	17668395	CNVD
Neonatal seizures	17668391	CNVD
Neuroticism	17667963	CNVD
Cancer	17916600	CNVD
Squamous cell cancer	19047905	CNVD
Multiple endocrine neoplasia type 1	19566914	CNVD
XY sex reversal	17503084	CNVD
Berardinelli-seip congenital generalized lipodystrophy	17668391	CNVD
Maculopathy	17646752	CNVD
Breast cancer	17899364	CNVD
Breast cancer	17157792	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	20877625	CNVD
Autism	22209245	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:46 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:64174400-64182600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
2	chr11:64174400-64182600	Weak transcription	HUES64 Cell Line	embryonic stem cell
3	chr11:64177400-64182600	Weak transcription	HUES6 Cell Line	embryonic stem cell
4	chr11:64178000-64184200	Weak transcription	Right Atrium	heart
5	chr11:64178200-64182600	Weak transcription	Fetal Thymus	thymus
6	chr11:64181200-64182600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
7	chr11:64182200-64183000	Enhancers	Fetal Muscle Leg	muscle
8	chr11:64182200-64183800	Enhancers	Spleen	Spleen
9	chr11:64182400-64182600	Weak transcription	H9 Cell Line	embryonic stem cell
10	chr11:64182400-64182600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
11	chr11:64182400-64182800	Enhancers	Fetal Stomach	stomach
12	chr11:64182400-64183000	Enhancers	Right Ventricle	heart
13	chr11:64182400-64183200	Enhancers	ES-WA7 Cell Line	embryonic stem cell
14	chr11:64182400-64183200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
15	chr11:64182400-64183200	Enhancers	Fetal Heart	heart
16	chr11:64182400-64183400	Enhancers	Fetal Lung	lung
17	chr11:64182400-64183600	Enhancers	H1 Cell Line	embryonic stem cell
18	chr11:64182400-64183600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
19	chr11:64182400-64183800	Enhancers	Placenta	Placenta
20	chr11:64182400-64184000	Enhancers	ES-I3 Cell Line	embryonic stem cell
21	chr11:64182400-64184000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
22	chr11:64182600-64182800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
23	chr11:64182600-64182800	Enhancers	H9 Cell Line	embryonic stem cell
24	chr11:64182600-64182800	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
25	chr11:64182600-64182800	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
26	chr11:64182600-64183000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
27	chr11:64182600-64183000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
28	chr11:64182600-64183000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
29	chr11:64182600-64183000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
30	chr11:64182600-64183200	Enhancers	HUES64 Cell Line	embryonic stem cell
31	chr11:64182600-64183200	Enhancers	Fetal Muscle Trunk	muscle
32	chr11:64182600-64183200	Enhancers	Fetal Thymus	thymus
33	chr11:64182600-64183400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
34	chr11:64182600-64183400	Enhancers	HUES48 Cell Line	embryonic stem cell
35	chr11:64182600-64183400	Enhancers	HUES6 Cell Line	embryonic stem cell
36	chr11:64182600-64183400	Enhancers	iPS-18 Cell Line	embryonic stem cell
37	chr11:64182600-64183600	Enhancers	iPS-15b Cell Line	embryonic stem cell
38	chr11:64182600-64183800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
39	chr11:64182800-64183200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
40	chr11:64182800-64183200	Enhancers	iPS-20b Cell Line	embryonic stem cell
41	chr11:64182800-64196000	Weak transcription	H9 Cell Line	embryonic stem cell
42	chr11:64183000-64183600	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
43	chr11:64183600-64183800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
44	chr11:64183600-64184000	Enhancers	Gastric	stomach
45	chr11:64183600-64186000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
46	chr11:64183800-64186600	Weak transcription	Placenta	Placenta

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links